Progyny Analyst Ratings
Progyny Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/09/2023 | 69.09% | JP Morgan | $58 → $57 | Maintains | Overweight |
| 09/27/2023 | 36.46% | Canaccord Genuity | → $46 | Initiates Coverage On | → Buy |
| 09/14/2023 | 42.39% | Cantor Fitzgerald | $45 → $48 | Maintains | Overweight |
| 08/11/2023 | 54.26% | Truist Securities | $48 → $52 | Maintains | Buy |
| 08/04/2023 | 48.32% | Keybanc | $45 → $50 | Maintains | Overweight |
| 05/22/2023 | 48.32% | BTIG | → $50 | Initiates Coverage On | → Buy |
| 05/15/2023 | 72.06% | JP Morgan | $61 → $58 | Maintains | Overweight |
| 05/09/2023 | 48.32% | B of A Securities | $40 → $50 | Maintains | Buy |
| 05/09/2023 | 33.49% | Cantor Fitzgerald | $44 → $45 | Maintains | Overweight |
| 04/21/2023 | 30.53% | Cantor Fitzgerald | → $44 | Initiates Coverage On | → Overweight |
| 01/05/2023 | 0.86% | SVB Leerink | $59 → $34 | Downgrades | Outperform → Market Perform |
| 12/19/2022 | 33.49% | Keybanc | $55 → $45 | Maintains | Overweight |
| 11/18/2022 | 83.92% | JP Morgan | $78 → $62 | Maintains | Overweight |
| 09/16/2022 | 63.16% | Keybanc | → $55 | Maintains | Overweight |
| 09/07/2022 | 66.12% | Truist Securities | → $56 | Initiates Coverage On | → Buy |
| 12/02/2021 | 77.99% | Jefferies | → $60 | Initiates Coverage On | → Buy |
| 09/30/2021 | 140.28% | Berenberg | → $81 | Initiates Coverage On | → Buy |
| 09/28/2021 | 137.32% | Barclays | $72 → $80 | Maintains | Overweight |
| 08/25/2021 | 113.59% | Barclays | $64 → $72 | Maintains | Overweight |
| 08/12/2021 | 89.85% | Barclays | → $64 | Initiates Coverage On | → Overweight |
| 08/06/2021 | 75.02% | SVB Leerink | $64 → $59 | Maintains | Outperform |
| 06/02/2021 | — | Guggenheim | Downgrades | Buy → Neutral | |
| 05/07/2021 | 89.85% | SVB Leerink | $58 → $64 | Maintains | Outperform |
| 03/10/2021 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 11/25/2020 | 3.83% | B of A Securities | $30 → $35 | Maintains | Neutral |
| 11/06/2020 | 48.32% | SVB Leerink | $44 → $50 | Maintains | Outperform |
| 08/24/2020 | 3.83% | JP Morgan | $30 → $35 | Maintains | Overweight |
| 08/06/2020 | -2.11% | Piper Sandler | $32 → $33 | Maintains | Overweight |
| 08/06/2020 | 30.53% | SVB Leerink | $35 → $44 | Maintains | Outperform |
| 08/06/2020 | -5.07% | Citigroup | $28 → $32 | Maintains | Buy |
| 07/27/2020 | -16.94% | B of A Securities | $26 → $28 | Maintains | Neutral |
| 07/01/2020 | 3.83% | SVB Leerink | → $35 | Initiates Coverage On | → Outperform |
| 06/02/2020 | -11.01% | Guggenheim | → $30 | Initiates Coverage On | → Buy |
| 05/13/2020 | -16.94% | Citigroup | $29 → $28 | Maintains | Buy |
| 03/10/2020 | -13.97% | Citigroup | $30 → $29 | Maintains | Buy |
| 12/04/2019 | -16.94% | B of A Securities | $26 → $28 | Reiterates | → Neutral |
| 11/19/2019 | -22.87% | JP Morgan | → $26 | Initiates Coverage On | → Overweight |
| 11/19/2019 | -16.94% | SVB Leerink | → $28 | Initiates Coverage On | → Outperform |
| 11/19/2019 | -11.01% | Citigroup | → $30 | Initiates Coverage On | → Buy |
| 11/19/2019 | -2.11% | Piper Sandler | → $33 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 10/09/2023 | 69.09% | 摩根大通 | $58→$57 | 维护 | 超重 |
| 09/27/2023 | 36.46% | 卡纳科特·格纳奇 | →$46 | 开始承保 | →购买 |
| 09/14/2023 | 42.39% | 康托·菲茨杰拉德 | $45→$48 | 维护 | 超重 |
| 2023年08月11日 | 54.26% | Truist证券 | $48→$52 | 维护 | 买 |
| 08/04/2023 | 48.32% | KeyBanc | $45→$50 | 维护 | 超重 |
| 2023年05月22日 | 48.32% | BTIG | →$50 | 开始承保 | →购买 |
| 2023年05月15日 | 72.06% | 摩根大通 | $61→$58 | 维护 | 超重 |
| 05/09/2023 | 48.32% | B of A证券 | $40→$50 | 维护 | 买 |
| 05/09/2023 | 33.49% | 康托·菲茨杰拉德 | $44→$45 | 维护 | 超重 |
| 04/21/2023 | 30.53% | 康托·菲茨杰拉德 | →$44 | 开始承保 | →超重 |
| 01/05/2023 | 0.86% | SVB Leerink | $59→$34 | 评级下调 | 跑赢→市场表现 |
| 2022年12月19日 | 33.49% | KeyBanc | $55→$45 | 维护 | 超重 |
| 2022年11月18日 | 83.92% | 摩根大通 | $78→$62 | 维护 | 超重 |
| 09/16/2022 | 63.16% | KeyBanc | →$55 | 维护 | 超重 |
| 09/07/2022 | 66.12% | Truist证券 | →$56 | 开始承保 | →购买 |
| 12/02/2021 | 77.99% | 杰富瑞 | →$60 | 开始承保 | →购买 |
| 09/30/2021 | 140.28% | 贝伦伯格 | →$81 | 开始承保 | →购买 |
| 09/28/2021 | 137.32% | 巴克莱 | $72→$80 | 维护 | 超重 |
| 2021/08/25 | 113.59% | 巴克莱 | $64→$72 | 维护 | 超重 |
| 2021/08/12 | 89.85% | 巴克莱 | →$64 | 开始承保 | →超重 |
| 08/06/2021 | 75.02% | SVB Leerink | $64→$59 | 维护 | 跑赢大盘 |
| 06/02/2021 | - | 古根海姆 | 评级下调 | 购买→中性 | |
| 05/07/2021 | 89.85% | SVB Leerink | $58→$64 | 维护 | 跑赢大盘 |
| 03/10/2021 | - | B of A证券 | 升级 | 中性→购买 | |
| 11/25/2020 | 3.83% | B of A证券 | $30→$35 | 维护 | 中性 |
| 11/06/2020 | 48.32% | SVB Leerink | $44→$50 | 维护 | 跑赢大盘 |
| 08/24/2020 | 3.83% | 摩根大通 | $30→$35 | 维护 | 超重 |
| 08/06/2020 | -2.11% | 派珀·桑德勒 | $32→$33 | 维护 | 超重 |
| 08/06/2020 | 30.53% | SVB Leerink | $35→$44 | 维护 | 跑赢大盘 |
| 08/06/2020 | -5.07% | 花旗集团 | $28→$32 | 维护 | 买 |
| 07/27/2020 | -16.94% | B of A证券 | $26→$28 | 维护 | 中性 |
| 07/01/2020 | 3.83% | SVB Leerink | →$35 | 开始承保 | →跑赢大盘 |
| 06/02/2020 | -11.01% | 古根海姆 | →$30 | 开始承保 | →购买 |
| 2020/05/13 | -16.94% | 花旗集团 | $29→$28 | 维护 | 买 |
| 03/10/2020 | -13.97% | 花旗集团 | $30→$29 | 维护 | 买 |
| 2019/12/04 | -16.94% | B of A证券 | $26→$28 | 重申 | →中性 |
| 2019年11月19日 | -22.87% | 摩根大通 | →$26 | 开始承保 | →超重 |
| 2019年11月19日 | -16.94% | SVB Leerink | →$28 | 开始承保 | →跑赢大盘 |
| 2019年11月19日 | -11.01% | 花旗集团 | →$30 | 开始承保 | →购买 |
| 2019年11月19日 | -2.11% | 派珀·桑德勒 | →$33 | 开始承保 | →超重 |
What is the target price for Progyny (PGNY)?
普罗吉尼(Progyny)的目标价是多少？
The latest price target for Progyny (NASDAQ: PGNY) was reported by JP Morgan on October 9, 2023. The analyst firm set a price target for $57.00 expecting PGNY to rise to within 12 months (a possible 69.09% upside). 13 analyst firms have reported ratings in the last year.
摩根大通于2023年10月9日报道了Progyny(纳斯达克代码：PGNY)的最新目标价。这家分析公司将目标价定为57.00美元，预计PGNY将在12个月内上涨(可能上涨69.09%)。过去一年，有13家分析公司公布了评级。
What is the most recent analyst rating for Progyny (PGNY)?
分析师对Progyny的最新评级是多少？
The latest analyst rating for Progyny (NASDAQ: PGNY) was provided by JP Morgan, and Progyny maintained their overweight rating.
纳斯达克(Sequoia Capital：PGNY)的最新分析师评级由摩根大通提供，普罗吉尼维持增持评级。
When is the next analyst rating going to be posted or updated for Progyny (PGNY)?
Progyny(PGNY)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Progyny, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Progyny was filed on October 9, 2023 so you should expect the next rating to be made available sometime around October 9, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Progyny的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Progyny的上一次评级是在2023年10月9日提交的，所以你应该预计下一次评级将在2024年10月9日左右提供。
Is the Analyst Rating Progyny (PGNY) correct?
分析师评级展望(PGNY)正确吗？
While ratings are subjective and will change, the latest Progyny (PGNY) rating was a maintained with a price target of $58.00 to $57.00. The current price Progyny (PGNY) is trading at is $33.71, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Progyny(PGNY)评级维持不变，目标价在58.00美元至57.00美元之间。目前Progyny的交易价格为33.71美元，超出了分析师的预测区间。